• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axonics, Inc. - Common Stock (NQ:AXNX)

70.98 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 70.98
Bid (Size) 70.96 (9)
Ask (Size) 71.00 (40)
Prev. Close 70.98
Today's Range 70.98 - 70.98
52wk Range 68.05 - 70.98
Shares Outstanding 46,134,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Axonics Reports Third Quarter 2024 Financial Results
November 07, 2024
From Axonics, Inc.
Via Business Wire
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
September 26, 2024
From Axonics, Inc.
Via Business Wire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+3.6%
+3.6%

More News

Read More
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
September 18, 2024
From Axonics, Inc.
Via Business Wire
Axonics Reports Second Quarter 2024 Financial Results
August 01, 2024
From Axonics, Inc.
Via Business Wire
Beyond The Numbers: 7 Analysts Discuss Axonics Stock
February 29, 2024
Via Benzinga
Analyst Scoreboard: 5 Ratings For Axonics
January 09, 2024
Via Benzinga
7 Robotics Stocks That Could Grow Your Wealth
July 22, 2024
Via InvestorPlace
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
May 16, 2024
From Axonics, Inc.
Via Business Wire
AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024
April 30, 2024
Via InvestorPlace
Axonics Reports First Quarter 2024 Financial Results
April 30, 2024
From Axonics, Inc.
Via Business Wire
Why Axonics Stock Soared Today
January 08, 2024
Via The Motley Fool
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
April 30, 2024
Via MarketBeat
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
April 18, 2024
Via Benzinga
Axonics Stockholders Approve Merger Agreement with Boston Scientific
March 22, 2024
From Axonics, Inc.
Via Business Wire
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
March 14, 2024
From Axonics, Inc.
Via Business Wire
Axonics Responds to ITC Action by Medtronic
February 29, 2024
From Axonics, Inc.
Via Business Wire
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From Axonics, Inc.
Via Business Wire
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
February 27, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
Why Medical Devices Giant Boston Scientific Shares Are Rising Today
January 31, 2024
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
January 12, 2024
Via Investor's Business Daily
Topics ETFs
Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
January 11, 2024
Via Benzinga
10 Top Stocks With a Strong Buy Rating Right Now
January 09, 2024
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via Benzinga

Frequently Asked Questions

Is Axonics, Inc. - Common Stock publicly traded?
Yes, Axonics, Inc. - Common Stock is publicly traded.
What exchange does Axonics, Inc. - Common Stock trade on?
Axonics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axonics, Inc. - Common Stock?
The ticker symbol for Axonics, Inc. - Common Stock is AXNX on the Nasdaq Stock Market
What is the current price of Axonics, Inc. - Common Stock?
The current price of Axonics, Inc. - Common Stock is 70.98
When was Axonics, Inc. - Common Stock last traded?
The last trade of Axonics, Inc. - Common Stock was at 11/14/24 04:00 PM ET
What is the market capitalization of Axonics, Inc. - Common Stock?
The market capitalization of Axonics, Inc. - Common Stock is 3.27B
How many shares of Axonics, Inc. - Common Stock are outstanding?
Axonics, Inc. - Common Stock has 3B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap